Schedule 13G ownership disclosure

ONCOMED PHARMACEUTICALS INC

Security class unavailable · CUSIP: 68234X102

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,348,212
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001332654-15-000001
Form type
SC 13G
Filer
Evoke Pharma Inc
CIK
CIK 1403708
Filed
Feb 11, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub